Neuronoff Inc., based in Cleveland, Ohio, is a clinical-stage medical device company specializing in injectable neuromodulation solutions. The company is advancing its Injectrode® platform, designed to provide minimally invasive, drug-free treatments for chronic pain and other conditions, towards FDA clearance and commercial launch. Neuronoff aims to eliminate the need for surgical incisions and reduce healthcare costs, offering a novel approach to neuromodulation therapies for a range of disorders, including autonomic, bladder, cardiac, and inflammatory conditions.
Leadership & Board
Current Number of Employees20
Current LinkedIn Followers4,113
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$10M
Total Amount Raised$10M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$5M
Latest Funding Amount$5M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Neuronoff Inc had 20 employees as of September 7, 2026. The number of employees increased by 0 (0.00%) week-over-week.
20Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Neuronoff Inc had 4,113 followers as of September 7, 2026. The number of followers increased by 4 (0.10%) week-over-week.
4,113Latest Followers Count
4(0.10%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.